Skip to main content
OpenTrials
Completed

NCT Number: NCT01889927

INSPIRE-CF: an Alternative Physiotherapy Model for Children With Cystic Fibrosis

The primary aim of the research is to evaluate whether an alternative model of cystic fibrosis (CF) physiotherapy care can produce statistically significant improvements in clinical and patient reported outcomes, and whether this alternative model is economically advantageous and/or sustainable.

Children randomised to the control group will receive 24-months of current model of CF care at Great Ormond Street Hospital (GOSH).

Children randomised to the intervention group will receive 24-months of current model of CF care at GOSH PLUS a weekly structured, individually prescribed and personally supervised exercise intervention at a local fitness facility or at school. The exercise prescription will include aerobic, anaerobic, strength, core conditioning and stretching components.

The main objectives of the study are:

1. Determine differences, if any, in lung function between the two groups; 2. Determine differences, if any, in exercise capacity between the two groups; 3. Evaluate cost of care of alternate model of care versus current model of care.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 year–15 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Great Ormond Street Hospital for Children NHS Foundation Trust

London, WC1N 3JH, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a documented diagnosis of Cystic Fibrosis;
  • Male or female aged 6 years or older at baseline and <17years old at the end of the 2-year study;
  • Currently under the primary care of the GOSH CF Unit;
  • Able to perform Spirometry with a baseline FEV1 percentage predicted of 40% or higher, as measured on at least 3 occasions in the previous year, during times of clinical stability (i.e. not during an exacerbation, and not during or within 2 weeks of intravenous antibiotics);
  • The participant's parent or legal guardian must be able to give informed consent; assent will be sought from all children.

Exclusion criteria

  • Patients who have had lung transplantation;
  • Patients listed for lung transplantation;
  • Clinically significant disease or medical condition other than CF or CF-related conditions that in the opinion of the multi-disciplinary clinical team, would compromise the safety of the patient;
  • Orthopaedic impairment that compromises exercise performance;
  • Mental impairment leading to inability to cooperate;
  • Unable to understand both verbal and/or written instructions English. Children will need to be able to understand exactly what the physiotherapists are instructing them do, for safe and effective exercise training sessions. Information sheets and questionnaires are only available in English;
  • Participants, parents or legal guardians who are unwilling to sign consent to participate in the study.

The following criteria will not exclude a child from participating in the study, but based on the hospital's exercise laboratory's infection control protocol, may preclude the participant from Cardiopulmonary Exercise Testing.

  • Patients with Methicillin-Resistant Staphylococcus Aureus;
  • Patients with Burkholderia Cepacia.

Treatment and study plan

Exercise intervention

Other

The exercise intervention will include aerobic, anaerobic, strength, core conditioning and stretching components.

Primary outcomes

  1. Forced expiratory volume in one second (FEV1)

    Time frame: Baseline, 6, 12 and 24-month intervals.

    Spirometry data will also to be collected at outpatient clinics, annual reviews and during hospital admissions.

Secondary outcomes

  1. Peak oxygen uptake (VO2Peak)

    Time frame: Baseline, 12 and 24-month intervals

    Gold standard exercise test to determine peak oxygen uptake during exercise

  2. 10m-Modified Shuttle Walk Test

    Time frame: Baseline, 6, 12 and 24 months

    Field test to assess functional exercise capacity. Distance covered and incremental level changes are evaluated over time.

  3. Lung Clearance Index

    Time frame: Baseline, 12 and 24 months

    Multiple breath washout test to evaluate for changes in small airways

  4. Height, weight, body mass index measurements

    Time frame: Baseline, 6, 12 and 24 months

    Height, weight and body mass index will be measured at regular intervals to evaluate for changes in growth parameters

  5. Cystic Fibrosis Questionnaire

    Time frame: Baseline, 12 and 24 months

    Disease specific questionnaire to evaluate changes in quality of life in cystic fibrosis

  6. Cost of care

    Time frame: Baseline, 12 and 24 months

    Evaluate differences in cost of care between the current model of CF care and the alternative model of care; and cost per patient.

Sponsors and collaborators

Lead sponsor

Great Ormond Street Hospital for Children NHS Foundation Trust

Other

Registry information

Official study title

INSPIRE-CF: A Randomised Controlled Trial Investigating the Clinical and Economic Benefits of an Alternative Model of Physiotherapy Care for Children With Cystic Fibrosis

Acronym: INSPIRE-CF

Important dates

Study start
2012
Primary completion
2017
Study completion
2017
First posted
Jul 1, 2013
Registry last updated
Sep 6, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.